Global Health Matters
Against the backdrop of increasing concerns around Omicron, last week we convened a media briefing on the biopharmaceutical industry’s efforts over the past year since the first COVID-19 vaccine was administered. This was a unique opportunity to share insights from the Biotechnology Innovation Organization (BIO) and the Developing Countries Vaccine Manufacturers’ ...
Read More
Innovation is crucial to identifying solutions to Africa’s healthcare needs. However, without the participation of women in the fields of Science, Technology, Engineering, and Mathematics (STEM), Africa and the world is bound to miss their invaluable perspectives and critical contributions. Women account for 30 percent of Sub-Saharan Africa's researchers and ...
Read More
This op-ed was originally published for Swissinfo on 16 December 2021. Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, calls for unrestricted access to pathogen sharing to help the world prepare for new variants and future pandemics. Before the Covid-19 pandemic, only experts knew what ...
Read More
In this blog, originally published on UHC2030, UHC2030’s Private Sector Constituency shares some examples of how the private sector contributes to strengthening health systems for UHC and health security. At least half the world’s population still lacks access to essential health services, and almost 100 million people are pushed into ...
Read More
This op-ed was originally published for Media Planet Value of Vaccines campaign on 9 December 2021. It is difficult to predict the nature of the next health threat. We do not know where, how or when it will hit. What we know is that playing catch is a lost battle. ...
Read More
This World AIDS Day, we mark 40 years since the first HIV case was identified. While there is much to reflect on, the most important takeaway is that there is still further to go to prevent new infections and treat the millions of people living with HIV/AIDS today. HIV has ...
Read More
This op-ed was originally published on Pharma Boardroom on 25 November 2021. The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers a unique opportunity to take a look back and share some important lessons learnt ...
Read More
Sometimes dubbed the “silent pandemic,” Antimicrobial Resistance (AMR) is a natural phenomenon that occurs when microorganisms such as bacteria adapt after repeated exposure to antibiotics, rendering treatments ineffective. It has been at the top of the global health agenda for many years, and young professionals in healthcare are acutely aware ...
Read More
This op-ed was originally published for Media Planet's AMR Campaign on 18 November 2021. For a long time, the world has recognised the threat posed by antimicrobial resistance (AMR) but the pipeline of new antibiotics to tackle it remains too weak. The WHO has recognised AMR as one of the ...
Read More
This op-ed was originally published for Media Planet's AMR Campaign on 18 November 2021. AMR is a silent pandemic that needs attention now. Globally, we need to take action or it will continue to claim lives. It’s been 18 months since the world was struck by the COVID-19 pandemic. Though ...
Read More
In December 2020, we witnessed a scientific feat that will go down in history books. This was just 10 months after the WHO declared COVID-19 a pandemic. While many welcomed the news and saw it as the best way to protect themselves and others around them, we knew that, as ...
Read More
For World Diabetes Day on 14 November, Ann-Lise Mikolajczak, Associate Manager, Value and Access and James Anderson, Executive Director of Global Health, sat down to discuss global diabetes care. This Q&A was developed in collaboration with HYPER Network, a platform for young industry professionals. Ann-Lise: The WHO Global Diabetes Compact ...
Read More
This op-ed was originally published on Foresight Global Health on 8 November 2021. The discovery of insulin in 1921 changed type 1 diabetes from a death sentence to a condition that can be controlled and managed successfully. Yet a hundred years later, children still die from diabetes, especially in low- and ...
Read More
This oped was originally published on Pharma Boardroom on 29 September 2021. Last flu season was exceptionally mild because of the measures used to contain COVID-19, like physical distancing and masks. But what will the upcoming flu season look like? Natural immunity against flu is likely to be lower because of last ...
Read More
This op-ed was originally published for Media Planet's Neglected Tropical Diseases campaign on 27 September 2021. The global burden of neglected tropical diseases (NTDs) affects over 1.7 billion people living in poverty, predominantly in South America, Africa and Asia. In the past decade, the global health community has made strides ...
Read More